Geron Corporation (GERN)

USD 1.3

(-6.16%)

Revenue Summary of Geron Corporation

  • Geron Corporation's latest annual revenue in 2023 was 237 Thousand USD , down -60.23% from previous year.
  • Geron Corporation's latest quarterly revenue in 2024 Q2 was 882 Thousand USD , up 190.13% from previous quarter.
  • Geron Corporation reported a annual revenue of 596 Thousand USD in annual revenue 2022, down -57.21% from previous year.
  • Geron Corporation reported a annual revenue of 1.39 Million USD in annual revenue 2021, up 450.59% from previous year.
  • Geron Corporation reported a quarterly revenue of 882 Thousand USD for 2024 Q2, up 190.13% from previous quarter.
  • Geron Corporation reported a quarterly revenue of 164 Thousand USD for 2023 Q3, up 465.52% from previous quarter.

Annual Revenue Chart of Geron Corporation (2023 - 1996)

Historical Annual Revenue of Geron Corporation (2023 - 1996)

Year Revenue Revenue Growth
2023 237 Thousand USD -60.23%
2022 596 Thousand USD -57.21%
2021 1.39 Million USD 450.59%
2020 253 Thousand USD -45.0%
2019 460 Thousand USD -56.85%
2018 1.06 Million USD 0.09%
2017 1.06 Million USD -82.72%
2016 6.16 Million USD -83.06%
2015 36.37 Million USD 3054.47%
2014 1.15 Million USD -10.13%
2013 1.28 Million USD -52.64%
2012 2.7 Million USD 11.12%
2011 2.43 Million USD -31.57%
2010 3.56 Million USD 106.43%
2009 1.72 Million USD -38.42%
2008 2.8 Million USD -63.22%
2007 7.62 Million USD 132.59%
2006 3.27 Million USD 1030.0%
2005 290 Thousand USD -72.46%
2004 1.05 Million USD -10.31%
2003 1.17 Million USD -5.93%
2002 1.24 Million USD -65.52%
2001 3.62 Million USD -45.23%
2000 6.6 Million USD 22.39%
1999 5.4 Million USD -20.59%
1998 6.8 Million USD -6.85%
1997 7.3 Million USD 37.74%
1996 5.3 Million USD 0.0%

Peer Revenue Comparison of Geron Corporation

Name Revenue Revenue Difference
AbCellera Biologics Inc. 38.02 Million USD 99.377%
Alkermes plc 1.66 Billion USD 99.986%
Agenus Inc. 156.31 Million USD 99.848%
Aptorum Group Limited 431.37 Thousand USD 45.06%
Ardelyx, Inc. 124.45 Million USD 99.81%
Dyadic International, Inc. 2.89 Million USD 91.824%
Eton Pharmaceuticals, Inc. 31.64 Million USD 99.251%
Lantern Pharma Inc. - USD -Infinity%
Inhibikase Therapeutics, Inc. 260.5 Thousand USD 9.021%
Novavax, Inc. 983.7 Million USD 99.976%
Janux Therapeutics, Inc. 8.08 Million USD 97.068%
Pyxis Oncology, Inc. - USD -Infinity%
TransCode Therapeutics, Inc. - USD -Infinity%
Ocuphire Pharma, Inc. 19.04 Million USD 98.756%
Outlook Therapeutics, Inc. - USD -Infinity%
Madrigal Pharmaceuticals, Inc. - USD -Infinity%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
SELLAS Life Sciences Group, Inc. - USD -Infinity%
Syros Pharmaceuticals, Inc. 9.93 Million USD 97.615%
Barinthus Biotherapeutics plc 802 Thousand USD 70.449%
Windtree Therapeutics, Inc. - USD -Infinity%
Xeris Biopharma Holdings, Inc. 163.91 Million USD 99.855%
Clearside Biomedical, Inc. 8.22 Million USD 97.119%
C4 Therapeutics, Inc. 20.75 Million USD 98.858%
Alnylam Pharmaceuticals, Inc. 1.82 Billion USD 99.987%
AlloVir, Inc. - USD -Infinity%
Arrowhead Pharmaceuticals, Inc. 240.73 Million USD 99.902%
VYNE Therapeutics Inc. 424 Thousand USD 44.104%
Bicycle Therapeutics plc 26.97 Million USD 99.121%
BioXcel Therapeutics, Inc. 1.38 Million USD 82.826%
ChromaDex Corporation 83.57 Million USD 99.716%
Chimerix, Inc. 324 Thousand USD 26.852%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Caribou Biosciences, Inc. 34.47 Million USD 99.313%
CRISPR Therapeutics AG 371.2 Million USD 99.936%
Precision BioSciences, Inc. 48.72 Million USD 99.514%
Fate Therapeutics, Inc. 63.53 Million USD 99.627%
Fortress Biotech, Inc. 84.51 Million USD 99.72%
Fortress Biotech, Inc. 84.51 Million USD 99.72%
HOOKIPA Pharma Inc. 20.12 Million USD 98.823%
ImmuCell Corporation 17.47 Million USD 98.644%
IDEAYA Biosciences, Inc. 23.38 Million USD 98.987%
Immix Biopharma, Inc. - USD -Infinity%
Incyte Corporation 3.69 Billion USD 99.994%
Innoviva, Inc. 310.46 Million USD 99.924%
IO Biotech, Inc. - USD -Infinity%
Jaguar Health, Inc. 9.76 Million USD 97.572%
Keros Therapeutics, Inc. 151 Thousand USD -56.954%
Ligand Pharmaceuticals Incorporated 131.31 Million USD 99.82%
ContextLogic Inc. 287 Million USD 99.917%
MiMedx Group, Inc. 321.47 Million USD 99.926%
MEI Pharma, Inc. 65.29 Million USD 99.637%
NextCure, Inc. - USD -Infinity%
Onconetix, Inc. 58.46 Thousand USD -305.371%
Oncternal Therapeutics, Inc. 785 Thousand USD 69.809%
Opthea Limited 261.85 Thousand USD 9.493%
Psyence Biomedical Ltd. - USD -Infinity%
Vaxcyte, Inc. - USD -Infinity%
PDS Biotechnology Corporation - USD -Infinity%
Precigen, Inc. 6.22 Million USD 96.193%
Pharming Group N.V. 245.31 Million USD 99.903%
Phathom Pharmaceuticals, Inc. 682 Thousand USD 65.249%
Pieris Pharmaceuticals, Inc. 42.81 Million USD 99.446%
PureTech Health plc 3.33 Million USD 92.883%
Rigel Pharmaceuticals, Inc. 116.88 Million USD 99.797%
Avidity Biosciences, Inc. 9.56 Million USD 97.521%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
Sangamo Therapeutics, Inc. 176.23 Million USD 99.866%
Sol-Gel Technologies Ltd. 1.55 Million USD 84.749%
Acelyrin, Inc. - USD -Infinity%
Salarius Pharmaceuticals, Inc. - USD -Infinity%
Summit Therapeutics Inc. - USD -Infinity%
Sensei Biotherapeutics, Inc. - USD -Infinity%
Senti Biosciences, Inc. 2.56 Million USD 90.746%
Stoke Therapeutics, Inc. 8.78 Million USD 97.301%
Elevation Oncology, Inc. - USD -Infinity%
Alaunos Therapeutics, Inc. 5000.00 USD -4640.0%
Telomir Pharmaceuticals, Inc. Common Stock - USD -Infinity%
Entrada Therapeutics, Inc. 129.01 Million USD 99.816%
VistaGen Therapeutics, Inc. 1.06 Million USD 77.726%
Kintara Therapeutics, Inc. - USD -Infinity%
Wave Life Sciences Ltd. 113.3 Million USD 99.791%
Seer, Inc. 15.18 Million USD 98.439%
Verrica Pharmaceuticals Inc. 5.12 Million USD 95.375%
Aadi Bioscience, Inc. 24.35 Million USD 99.027%
ESSA Pharma Inc. - USD -Infinity%
GlycoMimetics, Inc. 10 Thousand USD -2270.0%
GT Biopharma, Inc. - USD -Infinity%
Inhibrx Biosciences, Inc. 1.8 Million USD 86.833%
Akebia Therapeutics, Inc. 194.62 Million USD 99.878%
Catalyst Pharmaceuticals, Inc. 398.2 Million USD 99.94%
Longboard Pharmaceuticals, Inc. - USD -Infinity%
Orchestra BioMed Holdings, Inc. 2.76 Million USD 91.413%
Alzamend Neuro, Inc. - USD -Infinity%
Sorrento Therapeutics, Inc. 62.83 Million USD 99.623%
TRACON Pharmaceuticals, Inc. 12.04 Million USD 98.032%
Viracta Therapeutics, Inc. - USD -Infinity%
Rocket Pharmaceuticals, Inc. - USD -Infinity%
Aptose Biosciences Inc. - USD -Infinity%
ZyVersa Therapeutics, Inc. - USD -Infinity%
Soligenix, Inc. 839.35 Thousand USD 71.764%
Century Therapeutics, Inc. 2.23 Million USD 89.396%
Kura Oncology, Inc. - USD -Infinity%
TScan Therapeutics, Inc. 21.04 Million USD 98.874%
Intensity Therapeutics, Inc. - USD -Infinity%
Ocean Biomedical, Inc. - USD -Infinity%
CytomX Therapeutics, Inc. 101.21 Million USD 99.766%
Autolus Therapeutics plc 1.69 Million USD 86.042%
Mineralys Therapeutics, Inc. - USD -Infinity%
EyePoint Pharmaceuticals, Inc. 46.01 Million USD 99.485%
Eterna Therapeutics Inc. 68 Thousand USD -248.529%
Adaptive Biotechnologies Corporation 170.27 Million USD 99.861%
GRI Bio, Inc. 21.76 Million USD 98.911%
Xenetic Biosciences, Inc. 2.53 Million USD 90.669%
Tenaya Therapeutics, Inc. - USD -Infinity%
IGM Biosciences, Inc. 2.13 Million USD 88.873%
INmune Bio, Inc. 155 Thousand USD -52.903%
Heron Therapeutics, Inc. 127.04 Million USD 99.813%
SAB Biotherapeutics, Inc. 2.23 Million USD 89.415%
Pasithea Therapeutics Corp. - USD -Infinity%
Entero Therapeutics, Inc. - USD -Infinity%
Milestone Pharmaceuticals Inc. 1 Million USD 76.3%
X4 Pharmaceuticals, Inc. - USD -Infinity%
Atara Biotherapeutics, Inc. 8.57 Million USD 97.236%
Coherus BioSciences, Inc. 257.24 Million USD 99.908%
Verastem, Inc. - USD -Infinity%
Abeona Therapeutics Inc. 3.5 Million USD 93.229%
Pliant Therapeutics, Inc. 1.58 Million USD 85.0%
Tonix Pharmaceuticals Holding Corp. 7.76 Million USD 96.949%
Histogen Inc. 3.76 Million USD 93.712%
Aprea Therapeutics, Inc. 583.23 Thousand USD 59.364%
Surrozen, Inc. - USD -Infinity%
Organovo Holdings, Inc. 109 Thousand USD -117.431%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Ovid Therapeutics Inc. 391.69 Thousand USD 39.494%
Panbela Therapeutics, Inc. - USD -Infinity%
CASI Pharmaceuticals, Inc. 33.87 Million USD 99.3%
Cadrenal Therapeutics, Inc. Common Stock - USD -Infinity%
Centessa Pharmaceuticals plc 6.85 Million USD 96.542%
Hepion Pharmaceuticals, Inc. - USD -Infinity%
Arcturus Therapeutics Holdings Inc. 157.74 Million USD 99.85%
BioRestorative Therapies, Inc. 145.8 Thousand USD -62.551%
Apollomics, Inc. 821 Thousand USD 71.133%
Amarin Corporation plc 306.91 Million USD 99.923%
Mesoblast Limited 5.9 Million USD 95.984%
Turnstone Biologics Corp. 19.3 Million USD 98.772%
Kymera Therapeutics, Inc. 78.59 Million USD 99.698%
Synaptogenix, Inc. - USD -Infinity%
Tiziana Life Sciences Ltd - USD -Infinity%
Aurinia Pharmaceuticals Inc. 175.51 Million USD 99.865%
BriaCell Therapeutics Corp. - USD -Infinity%
Monopar Therapeutics Inc. - USD -Infinity%
Exelixis, Inc. 1.83 Billion USD 99.987%
Better Therapeutics, Inc. - USD -Infinity%
Nurix Therapeutics, Inc. 76.98 Million USD 99.692%
Apellis Pharmaceuticals, Inc. 396.59 Million USD 99.94%
NLS Pharmaceutics AG - USD -Infinity%
Dermata Therapeutics, Inc. - USD -Infinity%
Aridis Pharmaceuticals, Inc. - USD -Infinity%
Gritstone bio, Inc. 1.33 Million USD 82.194%
Jasper Therapeutics, Inc. - USD -Infinity%
TNF Pharmaceuticals, Inc. - USD -Infinity%
Avid Bioservices, Inc. 139.91 Million USD 99.831%
Insmed Incorporated 305.2 Million USD 99.922%
Virpax Pharmaceuticals, Inc. - USD -Infinity%
MediWound Ltd. 18.68 Million USD 98.732%
OmniAb, Inc. 34.16 Million USD 99.306%
Alector, Inc. 97.06 Million USD 99.756%
Seres Therapeutics, Inc. 126.32 Million USD 99.812%
Checkpoint Therapeutics, Inc. 103 Thousand USD -130.097%
Zai Lab Limited 266.71 Million USD 99.911%
Revance Therapeutics, Inc. 234.04 Million USD 99.899%
Aura Biosciences, Inc. - USD -Infinity%
Lyell Immunopharma, Inc. 130 Thousand USD -82.308%
Immunic, Inc. - USD -Infinity%
Tarsus Pharmaceuticals, Inc. 17.44 Million USD 98.642%
Veracyte, Inc. 361.05 Million USD 99.934%
InMed Pharmaceuticals Inc. 4.59 Million USD 94.845%
FibroGen, Inc. 147.75 Million USD 99.84%
SeaStar Medical Holding Corporation - USD -Infinity%
Adial Pharmaceuticals, Inc. - USD -Infinity%
Sonnet BioTherapeutics Holdings, Inc. 147.8 Thousand USD -60.346%
Jazz Pharmaceuticals plc 3.83 Billion USD 99.994%
Cyclacel Pharmaceuticals, Inc. 420 Thousand USD 43.571%
Amylyx Pharmaceuticals, Inc. 380.78 Million USD 99.938%
TG Therapeutics, Inc. 233.66 Million USD 99.899%
Galecto, Inc. - USD -Infinity%
Calithera Biosciences, Inc. - USD -Infinity%
Fortrea Holdings Inc. 3.1 Billion USD 99.992%
KalVista Pharmaceuticals, Inc. - USD -Infinity%
Aptevo Therapeutics Inc. - USD -Infinity%
XBiotech Inc. - USD -Infinity%
Jasper Therapeutics, Inc. - USD -Infinity%
Lyra Therapeutics, Inc. 1.55 Million USD 84.788%
Foghorn Therapeutics Inc. 34.15 Million USD 99.306%
Y-mAbs Therapeutics, Inc. 84.81 Million USD 99.721%
Theravance Biopharma, Inc. 57.42 Million USD 99.587%
Ultragenyx Pharmaceutical Inc. 434.24 Million USD 99.945%
Metagenomi, Inc. Common Stock 44.75 Million USD 99.47%
Vaxxinity, Inc. - USD -Infinity%
BioCryst Pharmaceuticals, Inc. 331.41 Million USD 99.928%
Gain Therapeutics, Inc. 55.18 Thousand USD -329.503%
Cartesian Therapeutics, Inc. 26 Million USD 99.089%
NexImmune, Inc. - USD -Infinity%
Creative Medical Technology Holdings, Inc. 9000.00 USD -2533.333%
Marker Therapeutics, Inc. 3.31 Million USD 92.842%
Regeneron Pharmaceuticals, Inc. 13.11 Billion USD 99.998%
Chemomab Therapeutics Ltd. - USD -Infinity%
Scopus BioPharma Inc. - USD -Infinity%
RAPT Therapeutics, Inc. - USD -Infinity%
Ainos, Inc. 122.11 Thousand USD -94.084%
Pluri Inc. 326 Thousand USD 27.301%
Prothena Corporation plc 91.37 Million USD 99.741%
Adaptimmune Therapeutics plc 60.28 Million USD 99.607%
Celularity Inc. 22.77 Million USD 98.959%
Rallybio Corporation - USD -Infinity%
Cue Biopharma, Inc. 5.49 Million USD 95.683%
MeiraGTx Holdings plc 14.01 Million USD 98.309%
Omeros Corporation - USD -Infinity%
Humacyte, Inc. - USD -Infinity%
Immunocore Holdings plc 249.42 Million USD 99.905%
Cocrystal Pharma, Inc. - USD -Infinity%
Cidara Therapeutics, Inc. 63.9 Million USD 99.629%
Blueprint Medicines Corporation 249.38 Million USD 99.905%
CalciMedica, Inc. - USD -Infinity%
Cabaletta Bio, Inc. - USD -Infinity%
Marinus Pharmaceuticals, Inc. 30.98 Million USD 99.235%
Scholar Rock Holding Corporation - USD -Infinity%
Sana Biotechnology, Inc. - USD -Infinity%
Pulmatrix, Inc. 7.29 Million USD 96.753%
Elicio Therapeutics, Inc. - USD -Infinity%
Vigil Neuroscience, Inc. - USD -Infinity%
Intellia Therapeutics, Inc. 36.27 Million USD 99.347%
Adlai Nortye Ltd. American Depositary Shares 4.99 Million USD 95.256%
Cytokinetics, Incorporated 7.53 Million USD 96.853%
Eloxx Pharmaceuticals, Inc. - USD -Infinity%
Nutriband Inc. 2.08 Million USD 88.635%
Protara Therapeutics, Inc. - USD -Infinity%
Vor Biopharma Inc. - USD -Infinity%
Roivant Sciences Ltd. 124.79 Million USD 99.81%
Evogene Ltd. 5.64 Million USD 95.798%
ProKidney Corp. - USD -Infinity%
Applied Therapeutics, Inc. 9.99 Million USD 97.628%
Hoth Therapeutics, Inc. - USD -Infinity%
BridgeBio Pharma, Inc. 9.3 Million USD 97.452%
CorMedix Inc. - USD -Infinity%
BioLineRx Ltd. 4.8 Million USD 95.063%
Tango Therapeutics, Inc. 36.52 Million USD 99.351%
Galectin Therapeutics Inc. - USD -Infinity%
Atai Life Sciences N.V. 314 Thousand USD 24.522%
Renovaro Biosciences Inc. - USD -Infinity%
Aerovate Therapeutics, Inc. - USD -Infinity%
Zentalis Pharmaceuticals, Inc. - USD -Infinity%
Sagimet Biosciences Inc. 2 Million USD 88.15%
MediciNova, Inc. 1 Million USD 76.3%
Praxis Precision Medicines, Inc. 2.44 Million USD 90.315%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -1288.808%
GeoVax Labs, Inc. - USD -Infinity%
Axsome Therapeutics, Inc. 270.6 Million USD 99.912%
Biomea Fusion, Inc. - USD -Infinity%
PTC Therapeutics, Inc. 937.82 Million USD 99.975%
Mereo BioPharma Group plc 10 Million USD 97.63%
Cullinan Oncology, Inc. - USD -Infinity%
Syndax Pharmaceuticals, Inc. - USD -Infinity%
Absci Corporation 5.71 Million USD 95.855%
NRx Pharmaceuticals, Inc. - USD -Infinity%
4D Molecular Therapeutics, Inc. 20.72 Million USD 98.856%
Dyne Therapeutics, Inc. - USD -Infinity%
Kiniksa Pharmaceuticals, Ltd. 270.25 Million USD 99.912%
Ventyx Biosciences, Inc. - USD -Infinity%
Allakos Inc. - USD -Infinity%
Imunon, Inc. - USD -Infinity%
Fulcrum Therapeutics, Inc. 2.8 Million USD 91.551%
Corcept Therapeutics Incorporated 482.37 Million USD 99.951%
BioAtla, Inc. - USD -Infinity%
NLS Pharmaceutics AG - USD -Infinity%
Bio-Path Holdings, Inc. - USD -Infinity%
Allogene Therapeutics, Inc. 95 Thousand USD -149.474%
Larimar Therapeutics, Inc. - USD -Infinity%
XOMA Corporation 4.75 Million USD 95.019%
Kezar Life Sciences, Inc. 7 Million USD 96.614%
Cara Therapeutics, Inc. 20.96 Million USD 98.87%
aTyr Pharma, Inc. 353 Thousand USD 32.861%
Aligos Therapeutics, Inc. 15.52 Million USD 98.474%
Akero Therapeutics, Inc. - USD -Infinity%
Viridian Therapeutics, Inc. 314 Thousand USD 24.522%
Eliem Therapeutics, Inc. - USD -Infinity%
EyeGate Pharmaceuticals, Inc. 12.05 Thousand USD -1865.337%
Akari Therapeutics, Plc - USD -Infinity%
Tevogen Bio Holdings Inc. - USD -Infinity%
Halozyme Therapeutics, Inc. 829.25 Million USD 99.971%
Lexaria Bioscience Corp. 226.2 Thousand USD -4.771%
UroGen Pharma Ltd. 82.71 Million USD 99.713%
Sutro Biopharma, Inc. 153.73 Million USD 99.846%
ZIVO Bioscience, Inc. 27.65 Thousand USD -757.143%
Orgenesis Inc. 530 Thousand USD 55.283%
Entera Bio Ltd. - USD -Infinity%
GH Research PLC - USD -Infinity%
Lisata Therapeutics, Inc. - USD -Infinity%
Reneo Pharmaceuticals, Inc. - USD -Infinity%
Xencor, Inc. 168.33 Million USD 99.859%
60 Degrees Pharmaceuticals, Inc. 253.57 Thousand USD 6.536%
Replimune Group, Inc. - USD -Infinity%
Coeptis Therapeutics Holdings, Inc. - USD -Infinity%
Vanda Pharmaceuticals Inc. 192.64 Million USD 99.877%
Lexaria Bioscience Corp. 226.2 Thousand USD -4.771%
Portage Biotech Inc. - USD -Infinity%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -1288.808%
Olema Pharmaceuticals, Inc. - USD -Infinity%
OncoCyte Corporation 1.5 Million USD 84.232%
Qualigen Therapeutics, Inc. 5.2 Million USD 95.446%
Processa Pharmaceuticals, Inc. - USD -Infinity%
Purple Biotech Ltd. - USD -Infinity%
CollPlant Biotechnologies Ltd. 10.95 Million USD 97.837%
scPharmaceuticals Inc. 13.59 Million USD 98.256%
ProMIS Neurosciences, Inc. - USD -Infinity%
HilleVax, Inc. - USD -Infinity%
NeuroSense Therapeutics Ltd. - USD -Infinity%
Tharimmune, Inc. - USD -Infinity%
Genprex, Inc. - USD -Infinity%
Neumora Therapeutics, Inc. Common Stock - USD -Infinity%
Atossa Therapeutics, Inc. - USD -Infinity%
XTL Biopharmaceuticals Ltd. - USD -Infinity%
Virios Therapeutics, Inc. - USD -Infinity%
OKYO Pharma Limited - USD -Infinity%
Savara Inc. - USD -Infinity%
Curis, Inc. 10.02 Million USD 97.635%
Daré Bioscience, Inc. 2.8 Million USD 91.559%
Carmell Therapeutics Corporation - USD -Infinity%
Titan Pharmaceuticals, Inc. 184 Thousand USD -28.804%
Achieve Life Sciences, Inc. - USD -Infinity%
BeiGene, Ltd. 2.45 Billion USD 99.99%
Kiromic BioPharma, Inc. - USD -Infinity%
Revolution Medicines, Inc. Warrant 11.58 Million USD 97.953%
Protagonist Therapeutics, Inc. 60 Million USD 99.605%
Erasca, Inc. - USD -Infinity%
bluebird bio, Inc. 29.49 Million USD 99.197%
Protagenic Therapeutics, Inc. - USD -Infinity%
BioMarin Pharmaceutical Inc. 2.41 Billion USD 99.99%
DBV Technologies S.A. 15.72 Million USD 98.493%
Protagenic Therapeutics, Inc. - USD -Infinity%
Moderna, Inc. 6.84 Billion USD 99.997%
Vincerx Pharma, Inc. - USD -Infinity%
Fresh Tracks Therapeutics, Inc. 8 Million USD 97.04%
Molecular Templates, Inc. 57.3 Million USD 99.586%
Acrivon Therapeutics, Inc. Common Stock - USD -Infinity%
Travere Therapeutics, Inc. 145.23 Million USD 99.837%
Monte Rosa Therapeutics, Inc. - USD -Infinity%
Spruce Biosciences, Inc. 10.08 Million USD 97.651%
Celldex Therapeutics, Inc. 6.88 Million USD 96.557%
Cogent Biosciences, Inc. - USD -Infinity%
MacroGenics, Inc. 58.74 Million USD 99.597%
RenovoRx, Inc. - USD -Infinity%
Adicet Bio, Inc. - USD -Infinity%
Prime Medicine, Inc. - USD -Infinity%
Aditxt, Inc. 645.17 Thousand USD 63.266%
Adagene Inc. 18.11 Million USD 98.691%
Estrella Immunopharma, Inc. - USD -Infinity%
Quantum-Si incorporated 1.08 Million USD 78.096%
Maravai LifeSciences Holdings, Inc. 288.94 Million USD 99.918%
Acurx Pharmaceuticals, Inc. - USD -Infinity%
Voyager Therapeutics, Inc. 250 Million USD 99.905%
SciSparc Ltd. 2.87 Million USD 91.768%
Vericel Corporation 197.51 Million USD 99.88%
Revelation Biosciences, Inc. - USD -Infinity%
Minerva Neurosciences, Inc. - USD -Infinity%
Generation Bio Co. 5.9 Million USD 95.986%
Astria Therapeutics, Inc. - USD -Infinity%
Black Diamond Therapeutics, Inc. - USD -Infinity%
Arcutis Biotherapeutics, Inc. 59.6 Million USD 99.602%
Invivyd, Inc. - USD -Infinity%
Relay Therapeutics, Inc. 25.54 Million USD 99.072%
Quoin Pharmaceuticals, Ltd. - USD -Infinity%
Spero Therapeutics, Inc. 96.73 Million USD 99.755%
Artelo Biosciences, Inc. - USD -Infinity%
2seventy bio, Inc. 100.38 Million USD 99.764%
ADMA Biologics, Inc. 258.21 Million USD 99.908%
Clene Inc. 654 Thousand USD 63.761%
Capricor Therapeutics, Inc. 25.17 Million USD 99.059%
Boundless Bio, Inc. Common Stock - USD -Infinity%
GeoVax Labs, Inc. - USD -Infinity%
Recursion Pharmaceuticals, Inc. 44.57 Million USD 99.468%
Citius Pharmaceuticals, Inc. - USD -Infinity%
Contineum Therapeutics, Inc. Class A Common Stock 50 Million USD 99.526%
Relmada Therapeutics, Inc. - USD -Infinity%
Finch Therapeutics Group, Inc. 107 Thousand USD -121.495%
ALX Oncology Holdings Inc. - USD -Infinity%
Vir Biotechnology, Inc. 86.18 Million USD 99.725%
Evaxion Biotech A/S 73.11 Thousand USD -224.16%
Ocular Therapeutix, Inc. 58.44 Million USD 99.594%
Verve Therapeutics, Inc. 11.75 Million USD 97.984%
Trevena, Inc. 3.12 Million USD 92.416%
Surrozen, Inc. - USD -Infinity%
Tyra Biosciences, Inc. - USD -Infinity%
Cingulate Inc. - USD -Infinity%
Galmed Pharmaceuticals Ltd. - USD -Infinity%
Unity Biotechnology, Inc. - USD -Infinity%
Tenax Therapeutics, Inc. - USD -Infinity%
Terns Pharmaceuticals, Inc. - USD -Infinity%
ACADIA Pharmaceuticals Inc. 726.43 Million USD 99.967%
Connect Biopharma Holdings Limited - USD -Infinity%
Clearmind Medicine Inc. - USD -Infinity%
Kronos Bio, Inc. 6.28 Million USD 96.231%
Bolt Biotherapeutics, Inc. 7.87 Million USD 96.991%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
Viking Therapeutics, Inc. - USD -Infinity%
Statera Biopharma, Inc. - USD -Infinity%
ImmunityBio, Inc. 622 Thousand USD 61.897%
Korro Bio, Inc. - USD -Infinity%
Kineta, Inc. 5.44 Million USD 95.645%
BioVie Inc. - USD -Infinity%
Codexis, Inc. 70.14 Million USD 99.662%
Celularity Inc. 22.77 Million USD 98.959%
Crinetics Pharmaceuticals, Inc. 4.01 Million USD 94.094%
Celcuity Inc. - USD -Infinity%
Virax Biolabs Group Limited 156.41 Thousand USD -51.516%
Cibus, Inc. 1.81 Million USD 86.957%
Eledon Pharmaceuticals, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. - USD -Infinity%
IN8bio, Inc. - USD -Infinity%
Kodiak Sciences Inc. - USD -Infinity%
Annexon, Inc. - USD -Infinity%
Adverum Biotechnologies, Inc. 3.6 Million USD 93.417%
Assembly Biosciences, Inc. 7.16 Million USD 96.691%
Avalo Therapeutics, Inc. 1.92 Million USD 87.682%
Ionis Pharmaceuticals, Inc. 787.64 Million USD 99.97%
Eyenovia, Inc. 3787.00 USD -6158.252%
Puma Biotechnology, Inc. 235.63 Million USD 99.899%
Conduit Pharmaceuticals Inc. - USD -Infinity%
Xilio Therapeutics, Inc. - USD -Infinity%
Arcellx, Inc. 110.31 Million USD 99.785%
Cardiff Oncology, Inc. 488 Thousand USD 51.434%
Enanta Pharmaceuticals, Inc. 79.2 Million USD 99.701%
Regulus Therapeutics Inc. - USD -Infinity%
Moolec Science SA 905.04 Thousand USD 73.814%
Acumen Pharmaceuticals, Inc. - USD -Infinity%
LAVA Therapeutics N.V. 6.76 Million USD 96.499%
Royalty Pharma plc 2.35 Billion USD 99.99%
Atea Pharmaceuticals, Inc. - USD -Infinity%
Greenwich LifeSciences, Inc. - USD -Infinity%
TFF Pharmaceuticals, Inc. 733.87 Thousand USD 67.705%
Mersana Therapeutics, Inc. 36.85 Million USD 99.357%
Humacyte, Inc. - USD -Infinity%
Structure Therapeutics Inc. - USD -Infinity%
89bio, Inc. - USD -Infinity%
PMV Pharmaceuticals, Inc. - USD -Infinity%
Avenue Therapeutics, Inc. - USD -Infinity%
Genelux Corporation 170 Thousand USD -39.412%
Trevi Therapeutics, Inc. - USD -Infinity%
Lexicon Pharmaceuticals, Inc. 1.2 Million USD 80.316%
Notable Labs, Ltd. 310 Thousand USD 23.548%
Liquidia Corporation 17.48 Million USD 98.645%
Mustang Bio, Inc. - USD -Infinity%
Immunovant, Inc. - USD -Infinity%
Quantum-Si incorporated 1.08 Million USD 78.096%
Arbutus Biopharma Corporation 18.14 Million USD 98.694%
DiaMedica Therapeutics Inc. - USD -Infinity%
Vera Therapeutics, Inc. 1.86 Million USD 87.272%
Acasti Pharma Inc. - USD -Infinity%
MiNK Therapeutics, Inc. - USD -Infinity%
Pasithea Therapeutics Corp. - USD -Infinity%
Xenon Pharmaceuticals Inc. - USD -Infinity%
Elevai Labs, Inc. Common Stock 1.71 Million USD 86.161%
NeuroBo Pharmaceuticals, Inc. - USD -Infinity%
Tempest Therapeutics, Inc. - USD -Infinity%
Soleno Therapeutics, Inc. - USD -Infinity%
PepGen Inc. - USD -Infinity%
Moleculin Biotech, Inc. - USD -Infinity%
United Therapeutics Corporation 2.32 Billion USD 99.99%
Nuvectis Pharma, Inc. - USD -Infinity%
Solid Biosciences Inc. - USD -Infinity%
BriaCell Therapeutics Corp. - USD -Infinity%
Immuneering Corporation - USD -Infinity%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Silo Pharma, Inc. 72.1 Thousand USD -228.701%
Belite Bio, Inc - USD -Infinity%
XOMA Corporation 4.75 Million USD 95.019%
ARS Pharmaceuticals, Inc. 30 Thousand USD -690.0%
Bionomics Limited - USD -Infinity%
Apogee Therapeutics, Inc. - USD -Infinity%
Alpha Tau Medical Ltd. - USD -Infinity%
uniQure N.V. 15.84 Million USD 98.504%
Cassava Sciences, Inc. - USD -Infinity%
Estrella Immunopharma, Inc. - USD -Infinity%
Poseida Therapeutics, Inc. 64.7 Million USD 99.634%
Forte Biosciences, Inc. - USD -Infinity%
Anebulo Pharmaceuticals, Inc. - USD -Infinity%
Enlivex Therapeutics Ltd. - USD -Infinity%
Conduit Pharmaceuticals Inc. - USD -Infinity%
SeaStar Medical Holding Corporation - USD -Infinity%
FibroBiologics, Inc. Common Stock - USD -Infinity%
Altimmune, Inc. 426 Thousand USD 44.366%
Amicus Therapeutics, Inc. 399.35 Million USD 99.941%
Alpha Tau Medical Ltd. - USD -Infinity%
Compugen Ltd. 33.45 Million USD 99.292%
Peak Bio, Inc. 367.87 Thousand USD 35.576%
Zevra Therapeutics, Inc. 27.46 Million USD 99.137%
Benitec Biopharma Inc. 216 Thousand USD -9.722%
Spyre Therapeutics, Inc. 886 Thousand USD 73.251%
NKGen Biotech, Inc. Common Stock - USD -Infinity%
Zura Bio Limited - USD -Infinity%
PolyPid Ltd. - USD -Infinity%
Aileron Therapeutics, Inc. - USD -Infinity%
NKGen Biotech, Inc. Warrants - USD -Infinity%
Instil Bio, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.981%
Immunome, Inc. 14.01 Million USD 98.309%
Compass Therapeutics, Inc. - USD -Infinity%
Verona Pharma plc - USD -Infinity%
enGene Holdings Inc. Warrants - USD -Infinity%
Shattuck Labs, Inc. 1.65 Million USD 85.697%
CervoMed Inc. 7.14 Million USD 96.683%
LENZ Therapeutics, Inc. - USD -Infinity%
Plus Therapeutics, Inc. 4.91 Million USD 95.176%
Dianthus Therapeutics, Inc. 2.82 Million USD 91.614%
Moolec Science SA 905.04 Thousand USD 73.814%
Enveric Biosciences, Inc. - USD -Infinity%
Inovio Pharmaceuticals, Inc. 832.01 Thousand USD 71.515%
AnaptysBio, Inc. 17.15 Million USD 98.619%
Design Therapeutics, Inc. - USD -Infinity%
Leap Therapeutics, Inc. - USD -Infinity%
NeurAxis, Inc. 2.46 Million USD 90.366%
Seelos Therapeutics, Inc. 2.2 Million USD 89.242%
Lumos Pharma, Inc. 2.05 Million USD 88.445%
Achilles Therapeutics plc - USD -Infinity%
enGene Holdings Inc. Common Stock - USD -Infinity%
180 Life Sciences Corp. - USD -Infinity%
Opiant Pharmaceuticals, Inc. 40.72 Million USD 99.418%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
Nutriband Inc. 2.08 Million USD 88.635%
ORIC Pharmaceuticals, Inc. - USD -Infinity%
CG Oncology, Inc. Common stock 204 Thousand USD -16.176%
Fractyl Health, Inc. Common Stock 120 Thousand USD -97.5%
Rani Therapeutics Holdings, Inc. - USD -Infinity%
MoonLake Immunotherapeutics - USD -Infinity%
Palisade Bio, Inc. 250 Thousand USD 5.2%
Tourmaline Bio, Inc. - USD -Infinity%
Beam Therapeutics Inc. 377.7 Million USD 99.937%
Neurogene Inc. - USD -Infinity%
Mirum Pharmaceuticals, Inc. 186.37 Million USD 99.873%
AEON Biopharma, Inc. - USD -Infinity%
CARGO Therapeutics, Inc. Common Stock - USD -Infinity%
Sesen Bio, Inc. 40 Million USD 99.408%
Enliven Therapeutics, Inc. - USD -Infinity%
Kiora Pharmaceuticals, Inc. - USD -Infinity%
Iovance Biotherapeutics, Inc. 1.18 Million USD 80.067%
Taysha Gene Therapies, Inc. 15.45 Million USD 98.466%
Athira Pharma, Inc. - USD -Infinity%
Vaccinex, Inc. 570 Thousand USD 58.421%
HCW Biologics Inc. 2.84 Million USD 91.66%
XOMA Corporation 4.75 Million USD 95.019%
Nektar Therapeutics 90.12 Million USD 99.737%
Arvinas, Inc. 78.5 Million USD 99.698%
Tevogen Bio Holdings Inc. - USD -Infinity%
Merus N.V. 43.94 Million USD 99.461%
Omega Therapeutics, Inc. 3.09 Million USD 92.34%
Quince Therapeutics, Inc. - USD -Infinity%
Rezolute, Inc. - USD -Infinity%
Clene Inc. 654 Thousand USD 63.761%
Indaptus Therapeutics, Inc. - USD -Infinity%
BeyondSpring Inc. 1.75 Million USD 86.465%
Synlogic, Inc. 3.37 Million USD 92.969%
Allarity Therapeutics, Inc. - USD -Infinity%
Phio Pharmaceuticals Corp. - USD -Infinity%
Peak Bio, Inc. 367.87 Thousand USD 35.576%
Werewolf Therapeutics, Inc. 19.94 Million USD 98.812%
Krystal Biotech, Inc. 50.69 Million USD 99.533%
Karyopharm Therapeutics Inc. 146.03 Million USD 99.838%
SpringWorks Therapeutics, Inc. 5.44 Million USD 95.649%
Lipella Pharmaceuticals Inc. 449.61 Thousand USD 47.288%
MannKind Corporation 198.96 Million USD 99.881%
Ikena Oncology, Inc. 9.16 Million USD 97.413%
Cyclerion Therapeutics, Inc. - USD -Infinity%
Gyre Therapeutics, Inc. 113.45 Million USD 99.791%
Gossamer Bio, Inc. - USD -Infinity%
CohBar, Inc. - USD -Infinity%
Cognition Therapeutics, Inc. - USD -Infinity%
NRx Pharmaceuticals, Inc. - USD -Infinity%
Legend Biotech Corporation 285.14 Million USD 99.917%
Mural Oncology plc - USD -Infinity%
Biora Therapeutics, Inc. 4000.00 USD -5825.0%
PaxMedica, Inc. Common Stock - USD -Infinity%
Disc Medicine, Inc. - USD -Infinity%
Champions Oncology, Inc. 50.15 Million USD 99.527%
REGENXBIO Inc. 90.24 Million USD 99.737%
Ensysce Biosciences, Inc. 2.23 Million USD 89.375%
Anavex Life Sciences Corp. - USD -Infinity%
Cellectar Biosciences, Inc. - USD -Infinity%
Edgewise Therapeutics, Inc. - USD -Infinity%
Vaxart, Inc. 7.37 Million USD 96.788%
PharmaCyte Biotech, Inc. - USD -Infinity%
Aldeyra Therapeutics, Inc. - USD -Infinity%
Cellectis S.A. 755 Thousand USD 68.609%
Longeveron Inc. 709 Thousand USD 66.573%
Repare Therapeutics Inc. 51.13 Million USD 99.537%
Sarepta Therapeutics, Inc. 1.24 Billion USD 99.981%
Inozyme Pharma, Inc. - USD -Infinity%
Revolution Medicines, Inc. 11.58 Million USD 97.953%
Nymox Pharmaceutical Corporation - USD -Infinity%
Third Harmonic Bio, Inc. - USD -Infinity%
ArriVent BioPharma, Inc. Common Stock - USD -Infinity%
AN2 Therapeutics, Inc. - USD -Infinity%
Anixa Biosciences, Inc. 210 Thousand USD -12.857%
Vertex Pharmaceuticals Incorporated 9.86 Billion USD 99.998%
Denali Therapeutics Inc. 330.53 Million USD 99.928%
Revelation Biosciences, Inc. - USD -Infinity%
Veru Inc. 16.29 Million USD 98.546%
Corvus Pharmaceuticals, Inc. - USD -Infinity%
Cingulate Inc. - USD -Infinity%
Passage Bio, Inc. - USD -Infinity%
Context Therapeutics Inc. - USD -Infinity%
Exicure, Inc. - USD -Infinity%
Day One Biopharmaceuticals, Inc. - USD -Infinity%
Oramed Pharmaceuticals Inc. 2.7 Million USD 91.232%
Scinai Immunotherapeutics Ltd. - USD -Infinity%
Rhythm Pharmaceuticals, Inc. 77.42 Million USD 99.694%
Nuvalent, Inc. - USD -Infinity%
ABVC BioPharma, Inc. 152.43 Thousand USD -55.481%
Carisma Therapeutics, Inc. 14.91 Million USD 98.411%
Unicycive Therapeutics, Inc. 675 Thousand USD 64.889%
OmniAb, Inc. 34.16 Million USD 99.306%
Anew Medical, Inc. - USD -Infinity%
Fennec Pharmaceuticals Inc. 21.25 Million USD 98.885%
Lipocine Inc. -2.85 Million USD 108.313%
Lexeo Therapeutics, Inc. Common Stock - USD -Infinity%
Nautilus Biotechnology, Inc. - USD -Infinity%
SAB Biotherapeutics, Inc. 2.23 Million USD 89.415%
G1 Therapeutics, Inc. 82.51 Million USD 99.713%
Bellerophon Therapeutics, Inc. - USD -Infinity%
Sage Therapeutics, Inc. 86.45 Million USD 99.726%
Ocugen, Inc. 6.03 Million USD 96.074%
Mind Medicine (MindMed) Inc. - USD -Infinity%
Q32 Bio Inc. 1.15 Million USD 79.498%
Brainstorm Cell Therapeutics Inc. - USD -Infinity%
Alumis Inc. Common Stock - USD -Infinity%
Equillium, Inc. 36.08 Million USD 99.343%
Kyverna Therapeutics, Inc. - USD -Infinity%
Coya Therapeutics, Inc. 6 Million USD 96.051%
CNS Pharmaceuticals, Inc. - USD -Infinity%
Galera Therapeutics, Inc. - USD -Infinity%
Evelo Biosciences, Inc. - USD -Infinity%
Comera Life Sciences Holdings, Inc. 633.1 Thousand USD 62.565%
Dominari Holdings Inc. 2.03 Million USD 88.377%
Edesa Biotech, Inc. - USD -Infinity%
vTv Therapeutics Inc. - USD -Infinity%
Bio-Techne Corporation 1.15 Billion USD 99.98%
Agios Pharmaceuticals, Inc. 26.82 Million USD 99.116%
Harmony Biosciences Holdings, Inc. 582.02 Million USD 99.959%
Prelude Therapeutics Incorporated - USD -Infinity%
Candel Therapeutics, Inc. - USD -Infinity%
iTeos Therapeutics, Inc. 12.59 Million USD 98.118%
Nkarta, Inc. - USD -Infinity%
BioCardia, Inc. 477 Thousand USD 50.314%
Iterum Therapeutics plc - USD -Infinity%